Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Donald J.A. Sutherland"'
Autor:
Michael A. Levesque, Barry Hoffman, Bhupinder Bharaj, Eleftherios P. Diamandis, Donald J.A. Sutherland, Maurizia Giai, Andreas Scorilas
Publikováno v:
Breast Cancer Research and Treatment. 61:111-119
Prostate Specific Antigen (PSA) expression by breast epithelial cells is associated with favorable breast cancer prognosis. In preliminary studies, we found that a nucleotide variation (G-->A) at position -158 in the androgen response element (ARE-1)
Autor:
Angeliki Magklara, Christina V. Obiezu, Margot H. Black, Donald J.A. Sutherland, D J Tindall, Michael A. Levesque, C Y F Young, Eleftherios P. Diamandis, Edward R. Sauter
Publikováno v:
British Journal of Cancer
The recent demonstration of human glandular kallikrein (hK2) expression in a breast carcinoma cell line has suggested that this putatively prostate-restricted, steroid hormone-regulated protease may also be expressed in breast epithelium in vivo and
Autor:
R Wilkinson, Wedad Hanna, S Mariz, Martin E. Blackstein, David R. McCready, William R. Geddie, Saul Sidlofsky, A Katz, P Dacamara, M Baida, G Stoik, Lavina Lickley, R W Hartwick, M Lipa, D Strongitharm, Donald J.A. Sutherland, Irene L. Andrulis, H Weizel, A Qizilbash, U Ambus, Kenneth P.H. Pritzker, C Mak, Shelley B. Bull
Publikováno v:
Journal of Clinical Oncology. 16:1340-1349
PURPOSE It remains a challenge to predict which women with axillary node-negative (ANN) breast cancer at greatest risk of relapse may benefit most from adjuvant therapy. Increases in neu/erbB-2 have been implicated in breast cancer prognosis. Althoug
Autor:
John M.L. Ebos, Joyce M. Slingerland, Maureen E. Trudeau, Mark Clemons, Shailendra Verma, Urban Emmenegger, Susan Dent, Robert S. Kerbel, Kathleen I. Pritchard, Robert Buckman, Donald J.A. Sutherland, Kathie Roche, Sandra Gardner, Nan Soon Wong, Gerrit E. DeBoer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(5)
Purpose Preclinical studies indicate that metronomic chemotherapy is antiangiogenic and synergistic with other antiangiogenic agents. We designed a phase I/II study to evaluate the safety and activity of adding dalteparin and prednisone to metronomic
Publikováno v:
Clinical biochemistry. 28(3)
To develop a highly sensitive immunofluorometric procedure for creatine kinase BB isoenzyme and use it to measure CK-BB in tumor cytosolic extracts and serum of cancer patients and healthy volunteers.For assay development, we used two monoclonal anti
Publikováno v:
Clinical biochemistry. 27(2)
Prostate-specific antigen (PSA) is believed to be a highly specific marker for normal or cancerous prostatic tissue. We recently found that immunoreactive PSA (IR-PSA) is present in 30% of breast tumor cytosols (from 525 breast cancer patients). In t
Publikováno v:
Breast cancer research and treatment. 30(2)
Breast tumors are thought to originate, grow, and metastasize in an environment which includes steroid hormone receptors, their cognate steroid ligands, and many gene products which are regulated by steroid hormone receptor-ligand complexes. In this
Publikováno v:
Breast cancer research and treatment. 32(3)
Prostate-specific antigen (PSA) is a glycoprotein produced by the epithelial cells of the prostate. PSA is currently used in clinical practice to facilitate diagnosis and monitoring of prostate carcinoma. The prostate is an organ that possesses andro
Autor:
Donald J.A. Sutherland, Judy-Anne W. Chapman, Eugene R. Tustanoff, Maureen E. Trudeau, Eamonn D. Ryan, H. Lavina A. Lickley, Wedad Hanna, Teik Chye Ooi, Carol Sawka, David R. McCready, Kathleen I. Pritchard, B.G. Mobbs
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 45(5)
Tumour estrogen receptor (ER) status may determine the medical treatment of a patient with breast cancer; yet inter-laboratory results can vary markedly, particularly when absolute cut-offs in fmol/mg cytosol protein are used. The use of standardized
Autor:
Judy-Anne W. Chapman, Donald J.A. Sutherland, Eamonn D. Ryan, Eugene R. Tustanoff, B.G. Mobbs, P.V.Narasimha Murthy, Teik Chye Ooi
Publikováno v:
European journal of cancer (Oxford, England : 1990). (9)
Breast carcinoma oestrogen receptor (ER) and progesterone receptor (PgR) values obtained by radioligand binding assays have commonly been observed to have approximate log-normal distributions. We examined the distribution of log-transformed receptor